Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2005 | 06-2004 | 06-2003 | 06-2002 | 06-2001 | |
| Sales | 13,460 | 16,440 | 22,180 | 13,670 | 30,060 |
| Cost of Goods | 3,550 | 4,750 | 4,830 | 4,260 | 0 |
| Gross Profit | 9,910 | 11,690 | 17,350 | 9,400 | 30,060 |
| Operating Expenses | 19,770 | 24,900 | 25,250 | 17,700 | 51,450 |
| Operating Income | -9,310 | -12,460 | -7,070 | -8,030 | -21,390 |
| Interest Expense | 40 | 120 | 80 | 190 | 340 |
| Other Income | 0 | 10 | -10 | -10 | 0 |
| Pre-tax Income | -9,350 | -12,570 | -7,160 | -8,230 | -21,730 |
| Income Tax | 2 | 0 | -5 | 20 | 30 |
| Net Income Continuous | -9,352 | -12,570 | -6,240 | -9,600 | -21,760 |
| Net Income | $-9,350 | $-12,570 | $-7,150 | $-8,250 | $-21,760 |
| EPS Basic Total Ops | -487.13 | -657.35 | -60.00 | -433.24 | -1,281.96 |
| EPS Basic Continuous Ops | -487.23 | -657.35 | -63.74 | -504.13 | -1,281.96 |
| EPS Diluted Total Ops | N/A | N/A | -60.00 | N/A | N/A |
| EPS Diluted Continuous Ops | N/A | N/A | -63.74 | N/A | N/A |
| EBITDA(a) | $-9,310 | $-12,460 | $-7,070 | $-8,030 | $-21,390 |